Taiwan Chip Stocks Rally as Nvidias 150B Spending Plans Boost Demand Outlook Energy Utilities Roundup Market Talk Highlights Sector Dynamics AIDriven Shift BlueCollar Skilled Trades Gain as EntryLevel WhiteCollar Jobs Slow Pakistan Deploys Paramilitary Force to Secure Strategic CopperGold Belt US Productivity Growth Slows in Q4 as Labor Costs Accelerate Raising Inflation Watch Home Depot HD Posts Steady Q1 2026 Results Positioning as a LowRisk Play IEX Q1 2026 Earnings EPS Surpasses Estimates on Strong Execution HOVR Q1 2026 Earnings WiderThanExpected Loss as Development Continues Stock Surges Over 26 Destination XL Group Q1 2026 Earnings Deep EPS Miss Sends Stock Lower CRNX Q1 2026 Earnings EPS Surprise Beats Estimates as PreRevenue Biotech Advances Pipeline Natural Resource Partners LP NRP Q1 2026 Earnings Solid EPS Amid Flat Revenue and Slight Stock Dip GTIM Q1 2026 Earnings Modest Profit Amid Challenging Environment ONEOK Inc OKE Holds Steady Near Support Level Amid Modest Pullback Power Solutions International PSIX Faces Selling Pressure as Key Support Levels Come into Focus Olenox Industries OLOX Edges Higher as Stock Tests Key Resistance Zone NB Bancorp Inc NBBK Slips 128 as Stock Hovers Near 20 Support Zone Mexco Energy MXC Jumps 428 Key Levels to Watch as Energy Stocks Gain Wingstop Shares Decline 12 as Recent Earnings Miss Analyst Expectations CMMB Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Biotech Continues Without Revenue RILYZ Bonds Edge Higher Amid Steady Market Activity JOE Q1 2026 Earnings EPS of 024 Reported Stock Edges Lower First Mid Bancshares FMBH Q1 2026 Earnings EPS Surpasses Expectations by 531 Amid Steady Performance Rogers Communication RCI Q1 2026 Earnings Modest EPS Miss Meets Positive Market Reception Northpointe Bancshares Inc NPB Q1 2026 Earnings EPS Misses Estimates Shares Dip in First Report as Public Company SCM Q1 2026 Earnings EPS Misses Estimates Despite 153 Stock Gain SKYH Q4 2025 Earnings Positive EPS Surprise Signals Operational Inflection Point ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy